Abstract
Regulated transgene expression is an integral component of gene therapies, cell therapies and biomanufacturing. However, transcription factor-based regulation, upon which most applications are based, suffers from complications such as epigenetic silencing that limit expression longevity and reliability. Constitutive transgene transcription paired with post-transcriptional gene regulation could combat silencing, but few such RNA- or protein-level platforms exist. Here we develop an RNA-regulation platform we call “PERSIST" which consists of nine CRISPR-specific endoRNases as RNA-level activators and repressors as well as modular OFF- and ON-switch regulatory motifs. We show that PERSIST-regulated transgenes exhibit strong OFF and ON responses, resist silencing for at least two months, and can be readily layered to construct cascades, logic functions, switches and other sophisticated circuit topologies. The orthogonal, modular and composable nature of this platform as well as the ease in constructing robust and predictable gene circuits promises myriad applications in gene and cell therapies.
Subject terms: Synthetic biology, CRISPR-Cas systems, Synthetic biology
Gene circuits must resist epigenetic silencing for reliable therapeutic applications. Here the authors develop an RNA-level regulation platform using CRISPR endoRNases that is modular, scalable, and more stable than traditional transcriptional versions.
Introduction
Transcription factor-based gene regulation in mammalian systems remains a cornerstone of both basic biological research and the field of synthetic biology. Transcription factor-promoter pairs such as the Tet-On or Tet-Off systems1–3 have been used extensively for transgene modulation while the robust behavior, modularity, composability, and large design space of many other additional transcriptional regulators4–7 have also enabled their layering into multi-transcription factor circuits for forward-design of complex cellular behavior. However, hurdles such as epigenetic silencing challenge the therapeutic and biomanufacturing potential of these strategies. Epigenetic silencing is the prevention of gene expression that is typically regulated by DNA methylation and chromatin remodeling (e.g., by histone modifications)8. Epigenetic silencing of transgenes has been observed in many therapeutically-relevant cell types including stem cells9, neurons10, and CHO cells11, and inhibits the engineered functions of these cells over time. While the location of genomic integration has been shown to be one factor that effects silencing12–17, other emerging factors such as features of promoter sequences11,18–22 and preferences for a transcriptionally active state9,23–26 make transcription factor-based gene regulation unsuitable in many contexts.
Recently developed post-transcriptional platforms comprising activator- and repressor-like regulators may be able to address this silencing problem. Such platforms would allow the use of constitutive promoters routinely employed in gene therapy, which tend to resist silencing27,28, and may also find use in modern therapeutic modalities such as mRNA gene therapies. Other options are the new protein-based protein-regulation platforms that use orthogonal proteases29–31 to control protein degradation. The field would benefit from the development of protein-based RNA-regulation platforms with similar properties that enable control of protein production, e.g., for regulation of secreted proteins. Some protein-based RNA-level regulators exist, mainly using translational repressors32–34 and RNA-cleaving Cas proteins35–41, but there is still a great need for demonstrated scalability and composability. Also, all of these examples canonically act as only repressor-like “OFF” switches; several RNA-based activator-like “ON” switches have been developed32,35,42–44, but none of these are composable for circuit engineering. The field currently lacks an RNA-acting activation/repression toolkit that is scalable, robust, modular, and composable to use in place of transcription factors.
Here we develop a post-transcriptional regulation platform that exploits RNA cleavage to control transcript degradation. We term this platform “Programmable Endonucleolytic Scission-Induced Stability Tuning” (PERSIST). We use CRISPR-specific endoribonucleases (endoRNases) as effectors for RNA cleavage-based regulation and adapt a set of nine that are orthogonal in their cleavage to serve as RNA-level “activators” and “repressors”. We create RNA-level ON-switch and OFF-switch motifs that can be engineered into the untranslated regions (UTRs) of transcripts and can be modified with a cognate endRNase RNA target sequence to be activated or repressed by specific endoRNases. The endoRNases exhibit up to 300-fold dynamic range as repressors and up to 100-fold dynamic range as activators in the PERSIST platform. When benchmarked against Tet-On, this regulatory modality is less vulnerable to silencing compared to transcriptional regulation because it can make use of vetted constitutive promoters routinely used in gene and cell therapies.
We demonstrate that our endoRNase platform exhibits modularity and composability by creating multi-level cascades, all 16 two-input Boolean logic functions, and a positive feedback motif. A useful feature of this platform is that these endoRNase regulators can function as both activators and repressors simultaneously, which allows for compact engineering of previously complex motifs such as a feed-forward loop and RNA-level bistable switch. The performance and simplicity of the PERSIST platform, combined with its resistance to silencing, will enable the facile construction of genetic circuits with extended functional lifetimes for applications in biomanufacturing, gene therapies, and engineered cell therapies.
Results
Development of RNA-level switches that respond to RNA cleavage and resist epigenetic silencing
We first set out to develop RNA-level switches that enable turning transgene expression on or off through the regulation of transcript degradation. Previous studies have shown that transcript cleavage, for example by miRNA45 or endoribonucleases35,46,47, can reduce transgene expression (Fig. 1a, left). Our initial objective was to develop an RNA-level ON switch that activates gene expression in response to programmable transcript cleavage. We designed this motif to have three domains (Fig. 1a, right): (1) RNA degradation signals that elicit rapid degradation of the transcript, (2) a cleavage domain that allows removal of the degradation tags, and (3) a stabilizer that ensures efficient translation and protects the mRNA after removal of the degradation signal. Thus, the transcript is degraded in the absence of a cleavage event and is stabilized post-cleavage.
First, we sought to identify a mechanism that leads to rapid mRNA degradation. A natural short 8bp RNA motif has been recently identified that binds heterogeneous nuclear ribonucleoproteins, which in turn recruit deadenylase complexes, resulting in mRNA degradation in a variety of cell types48. We created EYFP reporters that contain varied numbers of repeats (up to 30) of the degradation motif, “wt1”, within the 3′ UTR (Supplementary Figs. 1 and 2) and evaluated expression via transient transfection into HEK293FT cells. A reporter containing 30 repeats was efficiently degraded with over 300-fold reduction in fluorescence, while fewer numbers of repeats allowed for variable degrees of repression (Fig. 1b, Supplementary Figs. 3). Notably, while various methods exist to program RNA production, protein production and protein degradation (e.g., with promoter design49,50, upstream ORFs51, and destabilization domains52,53, respectively), repeats of these RNA degradation motifs represent a flexible way to fine-tune mRNA half-life.
Next, we searched for a genetic sequence that would stabilize the transcript and enable efficient translation after the removal of these degradation tags. Importantly, this element should not stabilize the transcript when the degradation tags are still present. An RNA triple helix (triplex) structure from the MALAT1 long-noncoding RNA54–56 has been used in several synthetic biology studies to stabilize engineered transcripts35,46,57. When we inserted the MALAT1 triplex upstream of 30 repeats of the wt1 degradation motif, the expression of the EYFP reporter remained low (Fig. 1c). Then, when we included a mascRNA sequence, which is cleaved naturally by endogenous RNase P, between the triplex and degradation motif, expression was restored to constitutive levels (Fig. 1c). Overall, this configuration exhibits a 166-fold increase in expression relative to the configuration lacking the RNAse P site, which is promising for its adaptation as an RNA-ON-switch motif for transgene regulation.
Based on these encouraging results, we next developed an endoRNAse-responsive ON switch using Csy4. The CRISPR endoRNase Csy4 (PaeCas6f) has been used as a translational repressor in mammalian synthetic biology previously35,46,47 and here we show that it can be repurposed to activate expression when its cleavage site is placed within the PERSIST-ON motif (Supplementary Figs. 4). It was important to validate the ability of this RNA-ON-switch to resist epigenetic silencing. We chose to benchmark the long-term inducibility of the Csy4-responsive PERSIST-ON-switch against the routinely used Tet-On system58. In the Tet-On transcriptional ON-switch, rtTA3 is induced by doxycycline (Dox) to activate the expression of the TRE promoter. We engineered both the Tet-On and PERSIST switches to drive the expression of the fluorescent protein mKO2 and compared it to a control construct encoding constitutive mKO2 expression from a hEF1a promoter (Fig. 1d). All three constructs were integrated into genomic landing pads located in the putative Rosa26 locus of CHO-K1 cells59 and polyclonal populations showed expected responses (Supplementary Figs. 5a). We then used single-cell sorting to generate 12 cell lines for each of four different conditions tested: (1) constitutive expression, (2) Tet-On switch maintained without Dox until induction, (3) Tet-On switch always maintained in the presence of Dox to simulate constitutive expression, and (4) PERIST ON-switch (Supplementary Fig. 5b). To evaluate response, each of the switches was induced (either by Dox addition or Csy4 transfection) 22 days and 55 days after sorting. We measured mKO2 levels in the presence and absence of the histone deacetylase (HDAC) inhibitor Trichostatin A (TSA) (Supplementary Fig. 5c), which would rescue any loss in response specifically due to silencing via deacetylation. We chose to evaluate an HDAC inhibitor because, as shown by Oyer et al.60, HDAC activity rather than DNA methylation was mainly responsible for driving epigenetic silencing of the Tet system. As seen in Fig. 1d both the constitutive reporter and the PERSIST-ON-switch respond similarly with and without TSA as indicated by their ± TSA ratio being close to one. This implies that both of these constructs resist HDAC-related epigenetic silencing. Interestingly, rescue with TSA addition was observed for the Tet-On system regardless of whether or not it was maintained in Dox, implying that both cases experience epigenetic silencing. Whether this effect is attributed to the properties of the Tet-On promoter sequence itself or the transcriptional activator, it is clear that the PERSIST-ON-switch under hEf1a promoter avoids these pitfalls and enables long-term robust yet regulatable response. The reliability of the response suggests that our post-transcriptional platform for transgene regulation could prove useful for applications where long-term control is required such as in cell therapies and biomanufacturing.
A CRISPR endoRNase library for the PERSIST platform
In order to generate a library of RNA-regulators, we next sought to evaluate whether other endoRNases besides Csy4 could cleave the transcript and activate the ON-switch motif or repress the OFF-switch motif. The Cas6 family that Csy4 belongs to and the Cas13 family of CRISPR-specific endonucleases cleave pre-crRNAs to produce shorter gRNA sequences used for DNA- or RNA-targeting respectively61. Importantly, these endonucleases cleave short, specific (often hairpin-structured) sequences called direct repeats, and orthologs of these endonucleases are thought to cleave their respective direct repeats orthogonally62. We hypothesized that these Cas6 and Cas13 families could provide a large number of parts that orthogonally cleave mRNAs when their cognate cleavage domain is engineered into the transcript. We evaluated nine total endonucleases, four from the Cas6 family: Csy4, Cse3 (TthCas6e)63, CasE (EcoCas6e)64 and Cas6 (PfuCas6-1)65 and five from the Cas13 family: LwaCas13a36, PspCas13b38,39, PguCas13b38,39, RanCas13b38,39, and RfxCas13d40. Since Csy4 and all of the Cas13 family endonucleases have previously been used in mammalian cells, only Cse3, CasE, and Cas6 required mammalian codon optimization; we made several other modifications to the Cas13 family endonucleases to improve performance and ensure compatibility with other endonucleases (Supplementary Fig. 6). We observed robust ON responses to most of these endoRNases when their cognate recognition sequences were placed between the triplex and degradation signal in the 3′ UTR-located PERSIST-ON-switch motif (Fig. 1e and Supplementary Figs 4 and 7). Interestingly, for some Cas endoRNases, the triplex was not required for ON-switch functionality (Supplementary Fig 7), likely due to the fact that these endoRNases stay bound to their cleaved product and protect the 3′-end of the transcript as previously shown66–68. The same set of endonucleases led to robust OFF responses of up to 300-fold repression when only their target sequences were placed into the transcript’s UTRs with larger repression occurring when placed in the 5’ UTR for those tested (Fig. 1e, Supplementary Fig. 8). We also evaluated PERSIST-ON- and OFF-switch dynamics in response to the endoRNase CasE (Supplementary Fig. 9) and verified that the PERSIST-ON-switch responds to CasE in several other relevant cell lines: CHO-K1, HeLa, and Jurkat (Supplementary Fig. 10), suggesting that the native degradation and stabilization mechanisms employed by the PERSIST platform are ubiquitous.
PERSIST switches demonstrate orthogonality, composability, and modularity
The repression and activation responses to CRISPR endoRNases in the 5′ UTR OFF-switch and 3′ UTR ON-switch positions respectively suggested that these proteins could be used as RNA-level activators and repressors for programmable gene circuits. To validate PERSIST as a platform that could be used in place of or alongside transcription factor-based regulation of genetic circuits, we next sought to evaluate the orthogonality, composability, and modularity of the Cas-based PERSIST switches as shown below.
We first evaluated the orthogonality of the Cas proteins by testing each Cas protein with every pairwise combination of Cas-responsive PERSIST-OFF and -ON reporters (Supplementary Fig. 11–13). Notably, CasE strongly cleaves the Cse3 recognition hairpin, but a single mutation U5A in the Cse3 recognition motif63 (Cse3*) renders it cleavable only by Cse3 and not CasE. As seen in Fig. 2a, the observed orthogonality suggests that subsets of this set of proteins could be used within the same circuit. Certain pairs, such as RanCas13b/PguCas13b and CasE/Cse3 (with the wt Case3 recognition site), should be avoided unless the cross-reactivity is beneficial for circuit design.
Next, we evaluated the composability of the PERSIST platform by layering the endonucleases. Here we make use of PEST-tagged endoRNases (Csy4, CasE, and Cse3)(Supplementary Fig. 14) in intermediate layers to promote faster state-switching which is useful for layered circuits. In Fig. 2b we demonstrate a two-stage repression cascade where one endoRNase (CasE) represses another (Csy4-PEST), that in turn represses a reporter. We show reporter EYFP expression as a function of CasE expression (proportional to mKO2 fluorescence) at three different Csy4:CasE ratios and with no Csy4. In the absence of Csy4, EYFP is strongly expressed (gray line). When varying amounts of Csy4 DNA are added and CasE is expressed at low levels, the reporter is also expressed at low levels. As the level of CasE increases, it represses Csy4, and expression of EYFP is restored. Note that at higher ratios of Csy4 to CasE, CasE is oversaturated and cannot fully repress Csy4, and therefore full fluorescence levels cannot be restored, likely because Csy4 is a slightly stronger repressor than CasE (see Fig. 1e). While other post-transcriptional platforms, namely protease-mediated regulation29–31, have similarly shown repression of another repressor, none have demonstrated direct activation of a repressor. Therefore, next, we demonstrate a two-stage activation/repression cascade where CasE activates Csy4, which, in turn, represses EYFP (Fig. 2c). In the absence of Csy4, EYFP is expressed strongly (gray line). When varying amounts of Csy4 DNA are added and CasE is expressed at low levels, Csy4 is not yet activated and the reporter remains highly expressed. As the level of CasE expression increases, it activates Csy4 which represses the reporter. Fig. 2d shows auto-positive feedback with endoRNase self-activation achieved by placing its recognition site in the 3′ ON-switch of its own transcript. The level of output fluorescence for the positive feedback is high for all transfection levels and, interestingly, seemed to even slightly surpass constitutive expression levels, perhaps due to increased mRNA stability provided by CasE binding.
We then sought to show that the Cas protein recognition sites provide modularity such that multiple recognition sites can be placed in a single transcript, in the 5′-OFF and/or 3′-ON PERSIST switch locations, and have predictable behavior. We demonstrate this modularity by creating all 16 two-input Boolean logic functions using transcripts targeted by multiple endoRNases (Fig. 3 and Supplementary Fig. 15). Importantly, multiple recognition sites can be combined within the same 5′ OFF or 3′ ON PERSIST motif (see “NOR” and “OR”) or within separate motifs on the same transcript (see “NIMPLY”). In fact 10 of the 16 logic gates can be constructed with a single transcript and they all perform well with dynamic ranges approaching two orders of magnitude. Importantly, all logic functions can be accurately identified using the same threshold values (gray region). Overall, these logic gates compare well to previous post-transcriptional platforms as well as DNA-based logic gates in mammalian cells69–71.
Dual function enables compact implementation of complex logic
Unlike transcription factors in DNA logic-based systems, which usually function to either repress or activate transcription, these endoRNases can act as both “activators” and “repressors” by placing their recognition sequence in a PERSIST-ON or PERSIST-OFF motif respectively. There are several transcriptional systems that have devised clever ways of switching between activation and repression6, but these systems show modest fold change and lack broad composability. Importantly, in the PERSIST platform, since a given endoRNase’s activation/repression function is determined by its target’s location, endoRNases can exhibit this dual functionality simultaneously. This is shown in Fig. 4a, where both a reporter encoding a Csy4-repressible tagBFP transcript and a reporter encoding a Csy4-activatable EYFP transcript can be acted on at the same time in the same cell by Csy4. As described below, we took advantage of this feature of the PERSIST platform to compactly build several motifs including a feed-forward loop (FFL) and a single-node positive feedback/repression motif, which in turn enabled a more robust three-stage cascade and a two-node bistable switch.
The coherent feed-forward loop (cFFL) motif provides redundant regulation, where regulation of a downstream gene via multiple pathways often yields a greater dynamic range. We hypothesized that a cFFL could increase the dynamic range of the PERSIST-ON response to an endoRNAse input. In our cFFL, CasE acts as the input and Csy4 as an intermediate node, where both act on the output (Fig. 4b). When CasE is absent, the reporter is both degraded by the ON switch motif and repressed by Csy4, resulting in 10-fold lower background expression than the PERSIST-ON-switch alone. When CasE is present, it directly activates the reporter and indirectly activates it by repressing Csy4. In this cFFL the input endoRNase simultaneously acts as an activator for the reporter and repressor for Csy4, resulting in dynamic ranges of over 1000-fold (Fig. 4b and Supplementary Fig. 16).
Auto-positive feedback is generally considered to have useful properties such as a response with a higher threshold, allowing for better separation between ON and OFF states; when auto-positive feedback then regulates a repressor, the repression response can also have a higher threshold. A dual-function PERSIST device can encode this functionality compactly (Fig. 5a). We constructed such a motif using Csy4 positive feedback and an EYFP OFF-switch reporter containing the Csy4 recognition site in its 5′ UTR (Fig. 5b). In a control experiment, when Csy4 functions just as a repressor, it is expressed stably and represses the reporter even at low levels. In a second control experiment, when Csy4 repressor contains the ON switch degradation tags but is unable to self-activate (the ON switch does not contain a recognition site), Csy4 transcript is degraded resulting in poor repression of the reporter. When the Csy4 recognition site is placed in the ON switch motif, Csy4 activates itself through a positive feedback loop and recovers its ability to target and repress the reporter.
We further demonstrate the robustness of this motif through the construction of a three-stage repression cascade (Fig. 5c and Supplementary Fig. 17). In a repression-only version of the cascade, there is indeed a drop in signal restoration at stage-2 (Fig. 5c, left), but this cascade still outperforms previous RNA-based repression cascades34. When positive feedback is included for stage 1 and 2, a larger percentage of stage-2 cells exhibit “ON” state behavior (Fig. 5c, right). There is, however, a trade-off as a larger percentage of stage three cells exhibit incorrect “ON” behavior when positive feedback is included.
To further demonstrate this motif’s utility we sought to create a bistable toggle switch. Notably, it has been shown that DNA-based toggle switch topologies that include positive auto-feedback loops at each node improve bistability compared to those with cross-repression alone72 and similarly that RNA-based switches relying only on cross-repression do not exhibit bimodality in an uninduced state34. Here, our positive feedback + repression motif enables the compact construction of a bistable toggle switch that requires only two nodes encoding both cross-repression and positive feedback. Csy4 and Cse3 both activate themselves as well as repress the other endoRNase (Fig. 5d). We design separate constructs containing fluorescent proteins (mKO2 and EYFP) that can be repressed by each of the endoRNases to track cell state. We then evaluated these constructs via transient poly-transfection73 to allow for many ratios of each node to be sampled (Fig. 5d, right and Supplementary Fig. 18). We achieved thorough sampling of node ratios by creating separate poly-transfection complexes for each node; we tracked the transfection efficiency of the Csy4 node containing the endoRNase plasmid and EYFP output using a constitutive tagBFP reporter while we measured the transfection efficiency of the CasE node containing the endoRNase plasmid and mKO2 output using an iRFP720 reporter. Cells transfected with both nodes (determined by tagBFP and iRFP720 fluorescence) exhibited two major states: a high-mKO2/low-EYFP state and low-mKO2/high-EYFP state. Promisingly, despite the wide range of ratios sampled, 97% of cells were in one state or the other and only 3% of cells expressed none or both fluorescent proteins, implying that this system is indeed bistable.
Discussion
Here we present a composable, scalable, and programmable RNA activation/repression platform that can be used in place of transcription factors. While other post-transcriptional platforms exist (e.g., protease-mediated regulation of protein degradation), to our knowledge, PERSIST is the first RNA-regulation platform that has demonstrated both composable activator- and repressor-like regulators. Protease-based regulation platforms29–31 have garnered much excitement and have advantages, for example, in situations such as mRNA therapy where circuits can be encoded on a single transcript. However, while innovative, the engineering complexities required for creating proteases that regulate not just an output protein but other proteases in more complex circuits hinder their robustness and modularity. For example, none of the protease platforms to date have been able to demonstrate protease-mediated direct activation of another single protease molecule. By separating the effector level (protein) from the level of the regulated substrate (mRNA) we have been able to simplify the design and composition of post-transcriptional regulatory motifs, which may allow these platforms to be used in more complex circuits. Together, both protease-based platforms and our PERSIST platform represent important steps in the synergistic development of post-transcriptional regulation capabilities for use in a wide variety of applications. Importantly, all post-transcriptional platforms enable the use of vetted strong constitutive promoters that resist epigenetic silencing. We show that the PERSIST platform can resist epigenetic silencing for at least 2 months, which can provide important benefits for durable long-term conditional gene expression in cell-based therapies and biomanufacturing.
Activation of an endoRNase by another endoRNase shown here was enabled by our development of an RNA-level ON switch, which has been a challenge in the field due to the fact that translation is typically “on” by default. While a primary focus of the work described here is endoRNase-based activation, we also explore whether our PERSIST-ON-switch can be directly activated by two other types of RNA cleavers: ribozymes (Supplementary Fig. 19) and miRNAs (Supplementary Fig. 20). Ribozyme-responsive PERSIST-ON switches could be useful for detecting endogenous ribozymes or regulating expression based on small molecules via aptazymes. Furthermore, with additional optimization, single-transcript miRNA-responsive PERSIST-ON switches could serve as genetically encoded reporters or actuators that detect and respond to high levels of miRNA. These so-called “miRNA high sensors” have been difficult to design and optimize in part because they often require a double-inversion step74 or multiple parts75. Therefore, it may be possible to extend the PERSIST platform for the detection of single-input and multi-input endogenous RNA cleavers such as disease-relevant endoRNases, ribozymes, and miRNAs.
We found that CRISPR endonucleases exhibit ~100-fold dynamic range in repression and >10-fold dynamic range inactivation through the PERSIST-OFF and -ON switches respectively. The fold dynamic range of the ON switch was further improved to >1000 by using an endoRNase-encoded cFFL. Using these endoRNases as RNA-level activators and repressors we demonstrate a range of genetic computations that give us confidence that this system could be used in place of transcription factor-based regulation in scenarios where epigenetic silencing could be problematic. In fact, unlike typical transcription factor operation, the repressor or activator functionality of the endoRNases is determined by the 5′ vs 3′ UTR location of their cognate recognition sites rather than encoded in the protein itself. While transcriptional logic often involves optimization of various repeats of operons with careful placement with respect to minimal promoters to achieve the desired response, programming with the PERSIST platform is straightforward and involves placing the target recognition sites either in the 5′ UTR PERSIST-OFF position or the 3′ UTR PERSIST-ON position. In another work, we have used CasE, one of the most robust endoRNases explored here, to implement an incoherent feed-forward loop that achieves control of gene expression regardless of DNA copy number and resource competition76. We also demonstrate that the unique dual functionality of these endoRNases in the PERSIST platform enables the facile engineering of useful motifs. These motifs allow for improved signal restoration and the creation of a compact RNA-level bistable toggle switch. The effective bistability combined with resistance to epigenetic silencing indicates that this switch could serve as a useful tool for studying and modulating cell fate decision making, development of cell type classifiers, and the creation of gene and cell therapies where strict ON or OFF states are required instead of a graded response, for example in cell-based manufacturing or safety switches. The development of small-molecule regulation would enable evaluation of the switch’s presumed ability to switch between states and maintain memory after inducer removal and would more generally enable endoRNase-based regulation to be modulated externally in a similar fashion to small-molecule-controllable transcription factors; these longer-term studies are the subject of ongoing work. Finally, here we explored a set of nine endoRNases and showed that they are largely orthogonal in their activity towards their cognate hairpins, which should enable their concurrent use in single circuit topologies. Given a large number of characterized Cas-family proteins with the ability to recognize and cleave specific RNA recognition motifs, PERSIST has the potential to expand beyond these nine proteins, making PERSIST scalable for the construction of large and complex genetic circuits. Taken together, the robustness, scalability, and modularity of the PERSIST platform and its ability to resist silencing promise the programming of sophisticated and reliable behavior in gene and cell therapies.
Methods
Plasmid cloning and circuit design
Hierarchical Golden Gate Assembly was used to assemble all expression constructs from “Level 0” (pL0) parts as published previously77. Here we create sub-pL0s that contain the PERSIST-ON-switch stabilizer, cut site, and degradation domains, which can be assembled using BbsI golden gate reactions into a 3′-UTR pL0. We also devise a “Level 2” cloning scheme using SapI golden gate reactions to assemble multiple transcription units onto a single plasmid (Supplementary Fig. 1). Cas6 family expressing plasmids were synthesized by IDT, while Cas13 family genes were cloned from plasmids purchased from addgene: pXR001: EF1a-CasRx-2A-EGFP (Plasmid #109049), pC0046-EF1a-PspCas13b-NES-HIV (Plasmid #103862), pC0045-EF1a-PguCas13b-NES-HIV (Plasmid #103861), pC0044-EF1a-RanCas13b-NES-mapk (Plasmid #103855), and pC014 - LwCas13a-msfGFP (Plasmid #91902). To ensure sufficiently fast circuit dynamics, a PEST tag was fused to any endoRNase within the circuit that is regulated by another endoRNAse.
Cell culture
HEK293FT (Invitrogen) cells were maintained in Dulbecco’s modified Eagle medium (DMEM, Corning) supplemented with 10% FBS (Corning), 1% Penicillin–Streptomycin-l-Glutamine (Corning), and 1% MEM Non-Essential Amino Acids (Gibco). CHO-K1 cells (ATCC) were maintained in Ham’s F-12K (Kaighn’s) medium supplemented with 10% FBS (Corning), 1% Penicillin–Streptomycin-l-Glutamine (Corning), and 1% MEM Non-Essential Amino Acids (Gibco). Doxycycline Hyclate (Dox, Sigma-Aldrich) was diluted in water at 10 mg/μL, stored at −20 ∘C, and used at a final concentration of 4 μM for experiments. Trichostatin A (TSA, Sigma-Aldrich) was diluted in DMSO, stored at −20 ∘C, and used at a final concentration of 100 nM for experiments.
Transfections
HEK293FT cell transfections were performed using Lipofectamine 3000 (invitrogen) with a 1.1:1.1:1 Lipofectamine 3000:P3000:DNA ratio in 24-well or 96-well format. Complexes were prepared in Opti-MEM (Gibco). 150,000–200,000 cells or 30,000–50,000 cells were plated on the day of transfection into 24-well or 96-well plates, respectively, in culture media without antibiotics and analyzed by flow cytometry after 48 hours. CHO-K1 cell transfections were performed using Lipofectamine LTX (invitrogen) with a 4:1:1 LTX:Plus Reagent:DNA ratio in 24-well or 96-well format. Complexes were prepared in Opti-MEM (Gibco). Cells were plated on the day of transfection and analyzed by flow cytometry after 48 hours.
Genomic integration
Constructs were integrated into CHO-K1 cells that had been previously engineered with a landing pad in their putative Rosa26 locus59. For payload integration, cells were transfected with engineered construct and BxBI expressing plasmid in 12-well plate format. After 3 days, media was supplemented with 8 μg/mL puromycin (invivogen) and 10 μg/mL blasticidin (invivogen). Cells were maintained under selection for 2 weeks with fresh media containing antibiotics refreshed every 2 days. After 2 weeks, cell lines were evaluated for response and underwent single-cell sorting.
Flow cytometry and single-cell sorting
Cell fluorescence was analyzed with LSR Fortessa flow cytometer, equipped with 405, 488, 561, and 637 nm lasers (BD Biosciences). The following laser and filter combinations were used to evaluate the fluorescent proteins used in transient transfection experiments in this study: tagBFP, 405 nm laser, 450/50 filter; EYFP, 488 nm laser and 515/20 nm filter; mKO2, 561 nm laser, 582/42 filter; iRFP, 640 nm laser, 780/60 filter. See Supplementary Fig. 21 for the sample gating strategy used for all experiments. Cell sorting was performed on a FACSAria cell sorter, equipped with 405, 488, 561, and 640 nm lasers. The following laser and filter combinations were used to evaluate the fluorescent proteins used in single-cell sorting: EBFP, 405 nm laser, 450/40 filter; EYFP, 488 nm laser, 530/30 filter; mKO2, 561 nm laser, 582/15 filter.
Data analysis
FACSDiva version 8.0.1 software was used to collect flow cytometry data. Analysis of flow cytometry data were performed in Excel and MATLAB with a custom analysis pipeline. For each data set, a compensation matrix is computed from single color controls to account for spectral bleed-through. After compensation, thresholds were set to evaluate positively transfected cells. For single construct analyses, linear fits were computed between transfection marker (typically tagBFP) and output (typically EYFP) expression levels using the nlinfit function (Supplementary Fig. 3). To evaluate fold change in response to endoRNases, slopes from fits were first normalized to those calculated from samples without the cognate endoRNase’s recognition site to eliminate non-specific effects associated with just endoRNase addition. For composite devices, points were fitted to a Michaelis–Menten saturation curve (Supplementary Fig. 15). For poly-transfection involving multiple plasmids, data were gated and binned before linear fits or summary statistics were calculated (Supplementary Fig. 4).
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Supplementary information
Acknowledgements
We thank Kevin Lebo and Ross Jones (MIT) for the discussion, Jin Huh (MIT) for parts, Leonid Gaidukov for providing landing pad cells, Allen Tseng for BxbI plasmid, Emerson Glassey for SapI cloning overhang analysis, and the Koch Flow Cytometry Core for assistance with single-cell sorting. This work was supported by the National Institutes of Health (R01-CA207029: R.W., R01-EB025854: R.W., and R01-CA206218: R.W.), National Science Foundation GRFP (1708200: B.D.).
Source data
Author contributions
B.D. and R.W. conceived the project and designed the experiments. B.D., N.W., E.H., and S.P. performed experiments. B.D. analyzed the data. B.D. and R.W. wrote the manuscript with input from all authors.
Peer review
Peer review information
Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Data availability
Representative plasmid sequences have been deposited to Genbank with the accession codes “OM256462 [https://www.ncbi.nlm.nih.gov/nuccore/OM256462]”, “OM256463 [https://www.ncbi.nlm.nih.gov/nuccore/OM256463]”, “OM256464 [https://www.ncbi.nlm.nih.gov/nuccore/OM256464]”, “OM256465 [https://www.ncbi.nlm.nih.gov/nuccore/OM256465]”, “OM256466 [https://www.ncbi.nlm.nih.gov/nuccore/OM256466]”. All plasmids used in this study are described in this paper and sequence information for parts is provided in Supplementary Data 1. Additional sequence information is available upon reasonable request from the authors. Raw .fcs files are available upon reasonable request. Source data are provided in this paper.
Code availability
Custom MATLAB scripts are used to process .fcs files, analyze data and generate plots are available upon reasonable request.
Competing interests
The Massachusetts Institute of Technology has filed patent applications on behalf of the inventors (B.D. and R.W.) for the RNA-ON switch platform described (US Provisional Application No. 16/049,042) as well as on behalf of the inventors (B.D., R.W., and N.W.) for the toggle switch described (US Provisional Application No. 17/122,087). The remaining authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Eileen Hu and Sebastian Palacios.
Supplementary information
The online version contains supplementary material available at 10.1038/s41467-022-30172-3.
References
- 1.Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA. 1992;89:5547–51. doi: 10.1073/pnas.89.12.5547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Urlinger S, et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. USA. 2000;97:7963–8. doi: 10.1073/pnas.130192197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Zhou X, Vink M, Klaver B, Berkhout B, Das AT. Optimization of the Tet-On system for regulated gene expression through viral evolution. Gene Ther. 2006;13:1382–1390. doi: 10.1038/sj.gt.3302780. [DOI] [PubMed] [Google Scholar]
- 4.Stanton BC, et al. Systematic transfer of prokaryotic sensors and circuits to mammalian cells. ACS Synth. Biol. 2014;3:891. doi: 10.1021/sb5002856. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Li Y, et al. Modular construction of mammalian gene circuits using TALE transcriptional repressors. Nat. Chem. Biol. 2015;11:207–213. doi: 10.1038/nchembio.1736. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kiani S, et al. Cas9 gRNA engineering for genome editing, activation and repression. Nat. Methods. 2015;12:1051–1054. doi: 10.1038/nmeth.3580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhang F, et al. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat. Biotechnol. 2011;29:149–153. doi: 10.1038/nbt.1775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Tolmachov, O. E., Subkhankulova, T. & Tolmachova, T. Silencing of Transgene Expression: A Gene Therapy Perspective. In Gene Therapy - Tools and Potential Applications (InTech, 2013). http://www.intechopen.com/books/gene-therapy-tools-and-potential-applications/silencing-of-transgene-expression-a-gene-therapy-perspective.
- 9.Ordovás L, et al. Efficient recombinase-mediated cassette exchange in hPSCs to study the hepatocyte lineage reveals AAVS1 locus-mediated transgene inhibition. Stem Cell Rep. 2015;5:918–931. doi: 10.1016/j.stemcr.2015.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Zhu P, et al. Silencing and un-silencing of tetracycline-controlled genes in neurons. PLoS ONE. 2007;2:e533. doi: 10.1371/journal.pone.0000533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kim M, O’Callaghan PM, Droms KA, James DC. A mechanistic understanding of production instability in CHO cell lines expressing recombinant monoclonal antibodies. Biotechnol. Bioeng. 2011;108:2434–2446. doi: 10.1002/bit.23189. [DOI] [PubMed] [Google Scholar]
- 12.Kotin R, Linden R, Berns K. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 1992;11:5071–5078. doi: 10.1002/j.1460-2075.1992.tb05614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Irion S, et al. Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat. Biotechnol. 2007;25:1477–1482. doi: 10.1038/nbt1362. [DOI] [PubMed] [Google Scholar]
- 14.Schröder AR, et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110:521–529. doi: 10.1016/S0092-8674(02)00864-4. [DOI] [PubMed] [Google Scholar]
- 15.Papapetrou EP, et al. Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells. Nat. Biotechnol. 2011;29:73–78. doi: 10.1038/nbt.1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Sadelain M, Papapetrou EP, Bushman FD. Safe harbours for the integration of new DNA in the human genome. Nat. Rev. Cancer. 2012;12:51–58. doi: 10.1038/nrc3179. [DOI] [PubMed] [Google Scholar]
- 17.Papapetrou EP, Schambach A. Gene insertion into genomic safe harbors for human gene therapy. Mol. Ther. 2016;24:678–684. doi: 10.1038/mt.2016.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hsu CC, et al. Targeted methylation of CMV and E1A viral promoters. Biochem. Biophys. Res. Commun. 2010;402:228–234. doi: 10.1016/j.bbrc.2010.09.131. [DOI] [PubMed] [Google Scholar]
- 19.Yang, Y., Mariati, Chusainow, J. & Yap, M. G. DNA methylation contributes to loss in productivity of monoclonal antibody-producing CHO cell lines. J. Biotechnol.147, 180–185 (2010). [DOI] [PubMed]
- 20.Papadakis E, Nicklin S, Baker A, White S. Promoters and control elements: designing expression cassettes for gene therapy. Curr. Gene Ther. 2005;4:89–113. doi: 10.2174/1566523044578077. [DOI] [PubMed] [Google Scholar]
- 21.Yamada M, Suzuki Y, Nagasaki SC, Okuno H, Imayoshi I. Light control of the tet gene expression system in mammalian cells. Cell Rep. 2018;25:487–500. doi: 10.1016/j.celrep.2018.09.026. [DOI] [PubMed] [Google Scholar]
- 22.Akitake CM, Macurak M, Halpern ME, Goll MG. Transgenerational analysis of transcriptional silencing in zebrafish. Dev. Biol. 2011;352:191–201. doi: 10.1016/j.ydbio.2011.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ayyub H, et al. DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease. Proc. Natl. Acad. Sci. 2017;114:E7526–E7535. doi: 10.1073/pnas.1703087114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Comet I, et al. Gene silencing triggers polycomb repressive complex 2 recruitment to CpG islands genome wide. Mol. Cell. 2014;55:347–360. doi: 10.1016/j.molcel.2014.06.005. [DOI] [PubMed] [Google Scholar]
- 25.Flury V, et al. The histone acetyltransferase Mst2 protects active chromatin from epigenetic silencing by acetylating the ubiquitin ligase Brl1. Mol. Cell. 2017;67:294–307. doi: 10.1016/j.molcel.2017.05.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Yu Y, Lowy MM, Elble RC. Tet-On lentiviral transductants lose inducibility when silenced for extended intervals in mammary epithelial cells. Metab. Eng. Commun. 2016;3:64–67. doi: 10.1016/j.meteno.2016.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wang X, et al. The EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells. J. Cell. Mol. Med. 2017;21:3044–3054. doi: 10.1111/jcmm.13216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Qin JY, et al. Systematic comparison of constitutive promoters and the doxycycline-inducible promoter. PLoS ONE. 2010;5:3–6. doi: 10.1371/journal.pone.0010611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Cella F, Wroblewska L, Weiss R, Siciliano V. Engineering protein-protein devices for multilayered regulation of mRNA translation using orthogonal proteases in mammalian cells. Nat. Commun. 2018;9:4392. doi: 10.1038/s41467-018-06825-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Gao XJ, Chong LS, Kim MS, Elowitz MB. Programmable protein circuits in living cells. Science. 2018;361:1252–1258. doi: 10.1126/science.aat5062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Fink T, et al. Design of fast proteolysis-based signaling and logic circuits in mammalian cells. Nat. Chem. Biol. 2019;15:115–122. doi: 10.1038/s41589-018-0181-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Saito H, et al. Synthetic translational regulation by an L7Ae-kink-turn RNP switch. Nat. Chem. Biol. 2010;6:71–78. doi: 10.1038/nchembio.273. [DOI] [PubMed] [Google Scholar]
- 33.Stapleton JA, et al. Feedback control of protein expression in mammalian cells by tunable synthetic translational inhibition. ACS Synth. Biol. 2012;1:83–88. doi: 10.1021/sb200005w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wroblewska, L. et al. Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery. Nat. Biotechnol. 33, 839–841 (2015). [DOI] [PMC free article] [PubMed]
- 35.Borchardt, E. K. et al. Controlling mRNA stability and translation with the CRISPR endoribonuclease Csy4. RNA21, 1921–1930 (2015). [DOI] [PMC free article] [PubMed]
- 36.Abudayyeh OO, et al. RNA targeting with CRISPR-Cas13. Nature. 2017;550:280–284. doi: 10.1038/nature24049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Abudayyeh OO, et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. 2016;353:aaf5573. doi: 10.1126/science.aaf5573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Cox DBT, et al. RNA editing with CRISPR-Cas13. Science. 2017;358:1019–1027. doi: 10.1126/science.aaq0180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Smargon AA, et al. Cas13b is a type VI-B CRISPR-associated RNA-guided rnase differentially regulated by accessory proteins Csx27 and Csx28. Mol. Cell. 2017;65:618–630. doi: 10.1016/j.molcel.2016.12.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Konermann S, et al. Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors. Cell. 2018;173:665–676. doi: 10.1016/j.cell.2018.02.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Yan WX, et al. Functionally diverse type V CRISPR-Cas systems. Science. 2019;363:88–91. doi: 10.1126/science.aav7271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Borchardt, E. K. et al. Inducing circular RNA formation using the CRISPR endoribonuclease Csy4. RNA23, 619–627 (2017). [DOI] [PMC free article] [PubMed]
- 43.Endo K, Hayashi K, Inoue T, Saito H. synthetic translational switches. Nat. Commun. 2013;4:1–9. doi: 10.1038/ncomms3393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Adamala KP, Martin-Alarcon DA, Boyden ES. Programmable RNA-binding protein composed of repeats of a single modular unit. Proc. Natl. Acad. Sci. 2016;113:E2579–E2588. doi: 10.1073/pnas.1519368113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Gam JJ, Babb J, Weiss R. A mixed antagonistic/synergistic miRNA repression model enables accurate predictions of multi-input miRNA sensor activity. Nat. Commun. 2018;9:2430. doi: 10.1038/s41467-018-04575-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Nissim L, Perli SD, Fridkin A, Perez-Pinera P, Lu TK. Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. Mol. Cell. 2014;54:698–710. doi: 10.1016/j.molcel.2014.04.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Yeo NC, et al. An enhanced CRISPR repressor for targeted mammalian gene regulation. Nat. Methods. 2018;15:611–616. doi: 10.1038/s41592-018-0048-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Geissler, R. et al. A widespread sequence-specific mRNA decay pathway mediated by hnRNP A1 and A2/B1. Genes Dev.30:1070–851 (2016). [DOI] [PMC free article] [PubMed]
- 49.Haberle V, Stark A. Eukaryotic core promoters and the functional basis of transcription initiation. Nat. Rev. Mol. Cell Biol. 2018;19:621–637. doi: 10.1038/s41580-018-0028-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Ferreira JP, Peacock RWS, Lawhorn IEB, Wang CL. Modulating ectopic gene expression levels by using retroviral vectors equipped with synthetic promoters. Syst. Synth. Biol. 2011;5:131–138. doi: 10.1007/s11693-011-9089-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Ferreira JP, Overton KW, Wang CL. Tuning gene expression with synthetic upstream open reading frames. Proc. Natl. Acad. Sci. USA. 2013;110:11284–9. doi: 10.1073/pnas.1305590110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Banaszynski LA, Chen L-c, Maynard-Smith LA, Ooi AGL, Wandless TJ. A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell. 2006;126:995–1004. doi: 10.1016/j.cell.2006.07.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Bonger KM, Chen L-c, Liu CW, Wandless TJ. Small-molecule displacement of a cryptic degron causes conditional protein degradation. Nat. Chem. Biol. 2011;7:531–537. doi: 10.1038/nchembio.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Wilusz JE, et al. A triple helix stabilizes the 3 9 ends of long noncoding RNAs that lack poly (A) tails. Genes Dev. 2012;26:2392–2407. doi: 10.1101/gad.204438.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Brown JA, et al. Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix. Nat. Struct. Mol. Biol. 2014;21:633–640. doi: 10.1038/nsmb.2844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Yario TA, Steitz JA, Valenstein ML, Brown JA, Tycowski KT. Formation of triple-helical structures by the 3’-end sequences of MALAT1 and MEN noncoding RNAs. Proc. Natl. Acad. Sci. 2012;109:19202–19207. doi: 10.1073/pnas.1217338109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Lee RTH, Ng ASM, Ingham PW. Ribozyme mediated gRNA Generation for in vitro and in vivo CRISPR/Cas9 mutagenesis. PLoS ONE. 2016;11:1–12. doi: 10.1371/journal.pone.0166020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Gossen, M. et al. Transcriptional activation by tetracyclines in mammalian cells. Science268, 1766–1769 (1995). [DOI] [PubMed]
- 59.Gaidukov, L. et al. A multi-landing pad DNA integration platform for mammalian cell engineering. Science46, 4072–4086 (2018). [DOI] [PMC free article] [PubMed]
- 60.Oyer JA, Chu A, Brar S, Turker MS. Aberrant epigenetic silencing is triggered by a transient reduction in gene expression. PLoS ONE. 2009;4:e4832. doi: 10.1371/journal.pone.0004832. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Hochstrasser ML, Doudna JA. Cutting it close: CRISPR-associated endoribonuclease structure and function. Trends Biochem. Sci. 2015;40:58–66. doi: 10.1016/j.tibs.2014.10.007. [DOI] [PubMed] [Google Scholar]
- 62.Niewoehner O, Jinek M, Doudna JA. Evolution of CRISPR RNA recognition and processing by Cas6 endonucleases. Nucleic Acids Res. 2014;42:1341–1353. doi: 10.1093/nar/gkt922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Sashital DG, Jinek M, Doudna JA. An RNA-induced conformational change required for CRISPR RNA cleavage by the endoribonuclease Cse3. Nat. Struct. Mol. Biol. 2011;18:680–687. doi: 10.1038/nsmb.2043. [DOI] [PubMed] [Google Scholar]
- 64.Jore MM, et al. Structural basis for CRISPR RNA-guided DNA recognition by cascade. Nat. Struct. Mol. Biol. 2011;18:529–536. doi: 10.1038/nsmb.2019. [DOI] [PubMed] [Google Scholar]
- 65.Carte J, Wang R, Li H, Terns RM, Terns MP. Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev. 2008;22:3489–3496. doi: 10.1101/gad.1742908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Haurwitz RE, Jinek M, Wiedenheft B, Zhou K, Doudna JA. Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science. 2010;329:1355–1358. doi: 10.1126/science.1192272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Kunin V, Sorek R, Hugenholtz P. Evolutionary conservation of sequence and secondary structures in CRISPR repeats. Genome Biol. 2007;8:R61. doi: 10.1186/gb-2007-8-4-r61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Brown JA, Kinzig CG, Degregorio SJ, Steitz JA. Hoogsteen-position pyrimidines promote the stability and function of the MALAT1 RNA triple helix. RNA. 2016;22:743–749. doi: 10.1261/rna.055707.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Ausländer, S., Ausländer, D., Müller, M., Wieland, M. & Fussenegger, M. Programmable single-cell mammalian biocomputers. Nature487, 123–127 (2012). [DOI] [PubMed]
- 70.Weinberg BH, et al. Large-scale design of robust genetic circuits with multiple inputs and outputs for mammalian cells. Nat. Biotechnol. 2017;35:453–462. doi: 10.1038/nbt.3805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Gaber, R. et al. Construction of logic circuits in mammalian cells. Nat. Chem. Biol.10, 203–208 (2014). [DOI] [PubMed]
- 72.Lebar, T. et al. A bistable genetic switch based on designable DNA-binding domains. Nat. Commun.5, 5007 (2014). [DOI] [PubMed]
- 73.Gam JJ, DiAndreth B, Jones RD, Huh J, Weiss R. A ‘poly-transfection’ method for rapid, one-pot characterization and optimization of genetic systems. Nucleic Acids Res. 2019;47:e106–e106. doi: 10.1093/nar/gkz623. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Xie Z, Wroblewska L, Prochazka L, Weiss R, Benenson Y. Multi-input RNAi-based logic circuit for identification of specific cancer cells. Science. 2011;333:1307–11. doi: 10.1126/science.1205527. [DOI] [PubMed] [Google Scholar]
- 75.Wang, X. W. et al. A microRNA-inducible CRISPR-Cas9 platform serves as a microRNA sensor and cell-type-specific genome regulation tool. Nat. Cell Biol.21, 522–530 (2019). [DOI] [PubMed]
- 76.Jones RD, et al. An endoribonuclease-based feedforward controller for decoupling resource-limited genetic modules in mammalian cells. Nat. Commun. 2020;11:5690. doi: 10.1038/s41467-020-19126-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Duportet, X. et al. A platform for rapid prototyping of synthetic gene networks in mammalian cells. Nucleic Acids Res.42, 13440–13451 (2018). [DOI] [PMC free article] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Representative plasmid sequences have been deposited to Genbank with the accession codes “OM256462 [https://www.ncbi.nlm.nih.gov/nuccore/OM256462]”, “OM256463 [https://www.ncbi.nlm.nih.gov/nuccore/OM256463]”, “OM256464 [https://www.ncbi.nlm.nih.gov/nuccore/OM256464]”, “OM256465 [https://www.ncbi.nlm.nih.gov/nuccore/OM256465]”, “OM256466 [https://www.ncbi.nlm.nih.gov/nuccore/OM256466]”. All plasmids used in this study are described in this paper and sequence information for parts is provided in Supplementary Data 1. Additional sequence information is available upon reasonable request from the authors. Raw .fcs files are available upon reasonable request. Source data are provided in this paper.
Custom MATLAB scripts are used to process .fcs files, analyze data and generate plots are available upon reasonable request.